PT Bank Mandiri (Persero) (BMRI) Q4 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2023 earnings summary
31 Oct, 2026Executive summary
FY23 PATMI rose 33.7% YoY to Rp55.1Tn; loans grew 16.3% and ROE reached 23.2%.
Growth was supported by higher PPOP, lower provisions, improving asset quality and digital-channel activity.
Financial highlights
FY23 total operating income increased 10.4% YoY to Rp138.7Tn; net interest income rose 9.08% to Rp95.9Tn and non-interest income gained 15.5% to Rp40.6Tn.
PPOP grew 17.3% to Rp84.8Tn; provision expense fell 37.1% to Rp10.1Tn, while operating expenses increased 1.14% to Rp53.9Tn.
4Q23 PATMI reached Rp16.0Tn, up 52.1% YoY and 15.6% QoQ; non-interest income climbed 26.6% YoY to Rp13.3Tn.
FY23 total assets rose 9.12% YoY to Rp2,174Tn; deposits increased 5.78% to Rp1,577Tn and CASA deposits grew 7.05% to Rp1,172Tn.
Outlook and guidance
FY24 consolidated loan growth guidance is 13–15%, with NIM of 5.3–5.5% and credit cost of 1.0–1.2%.
Loan growth priorities include value-chain lending and higher-yield Commercial, Micro, SME and Consumer segments.
NIM support factors include ample LDR and CASA prioritization; loan yields are expected to remain broadly flattish.
Credit costs are expected to normalize with provision reversals, while maintaining a stable coverage ratio.
Latest events from PT Bank Mandiri (Persero)
- Net income reached Rp31.6T, assets Rp2,528T, CAR 17.88%, and NPL 1.01% in 1H26.BMRI
Q2 2026 - Net profit up 16.6% YoY to Rp16.21t, CAR 19.96%, NPL 1.02%, digital and sustainability gains.BMRI
Q1 2026 - Net profit hit Rp61.3T, assets rose, and asset quality and capital adequacy stayed strong.BMRI
Q4 2025 - Loan growth led at 11% YoY, but profit fell 10.2% amid higher costs and NIM pressure.BMRI
Q3 2025 - Loan growth led the market, but profit fell on one-off costs; asset quality stayed strong.BMRI
Q2 2025 - Net income hit Rp46.08T, assets Rp2,324T, and loan growth reached 20.8% YoY.BMRI
Q3 2024 - 1H24 net profit reached Rp29.27T, assets Rp2,257.8T, and CAR 20.14% amid strong growth.BMRI
Q2 2024 - Q1 2025 net income up 2.9% to Rp14.53T, assets at Rp2,463.7T, with strong loan growth.BMRI
Q1 2025 - 2024 net profit up 1.3% to IDR 55.8T, with strong loan growth, digital gains, and robust asset quality.BMRI
Q4 2024